An open-label phase II study of buparlisib (BKM120) in patients with relapsed and refractory diffuse large B-cell lymphoma, mantle cell lymphoma or follicular ymphoma Meeting Abstract
| Authors: | Younes, A.; Salles, G.; Bociek, R. G.; Martinelli, G.; Caballero, D.; Barca, E. G.; Mukherjee, N.; Williams, L.; Herbst, F.; Tavorath, R.; Kim, W. S. |
| Abstract Title: | An open-label phase II study of buparlisib (BKM120) in patients with relapsed and refractory diffuse large B-cell lymphoma, mantle cell lymphoma or follicular ymphoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243504169 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.1718.1718 |
| Notes: | Meeting Abstract: 1718 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
